News/ US Solomon quits as Akari CEO following credit card probe Richard Staines Akari Therapeutics, Biotech, David Horn Solomon, people, Rare diseases 0 Comment Biotech veteran quits after less than a year in charge Share X Solomon quits as Akari CEO following credit card probe https://pharmaphorum.com/news/solomon-quits-as-akari-ceo-following-credit-card-probe/
News Akari soars ahead of read-out for Soliris rival Andrew McConaghie Akari Therapeutics, Alexion, Rare diseases, Soliris 0 Comment Investors are anticipating good news from a potential rival to Alexion’s rare disease blockbuster Soliris, with shares in Share X Akari soars ahead of read-out for Soliris rival https://pharmaphorum.com/news/akari-soliris-rival/